These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 350513)

  • 1. Studies on uptake of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296) by Candida albicans.
    Sakurai K; Sakaguchi T; Yamaguchi H; Iwata K
    Chemotherapy; 1978; 24(3):146-53. PubMed ID: 350513
    [No Abstract]   [Full Text] [Related]  

  • 2. Mode of action of 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt (Hoe 296).
    Sakurai K; Sakaguchi T; Yamaguchi H; Iwata K
    Chemotherapy; 1978; 24(2):68-76. PubMed ID: 340169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the mechanism of antifungal action of ciclopiroxolamine/Inhibition of transmembrane transport of amino acid, K+ and phosphate in Candida albicans cells (author's transl)].
    Iwata K; Yamaguchi H
    Arzneimittelforschung; 1981; 31(8A):1323-7. PubMed ID: 7028046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Penetration and antifungal activity of ciclopiroxolamine in hornified tissue (author's transl)].
    Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1353-9. PubMed ID: 7197542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungistatic activity, uptake and incorporation of 5-fluorocytosine in Candida albicans, as influenced by pyrimidines and purines. II. Studies on distribution and incorporation.
    Polak A; Scholer HJ
    Pathol Microbiol (Basel); 1973; 39(5):334-7. PubMed ID: 4580714
    [No Abstract]   [Full Text] [Related]  

  • 6. Penetration of Candida biofilms by antifungal agents.
    Al-Fattani MA; Douglas LJ
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3291-7. PubMed ID: 15328087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyene resistant Candida albicans: a proposed nutritional influence.
    Hammond SM; Kliger BN
    Microbios; 1974 Apr; 10(38):97-101. PubMed ID: 4604922
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyridone alkaloids from a marine-derived fungus, Stagonosporopsis cucurbitacearum, and their activities against azole-resistant Candida albicans.
    Haga A; Tamoto H; Ishino M; Kimura E; Sugita T; Kinoshita K; Takahashi K; Shiro M; Koyama K
    J Nat Prod; 2013 Apr; 76(4):750-4. PubMed ID: 23496341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microbiological laboratory studies with ciclopiroxolamine (author's transl)].
    Dittmar W; Grau W; Raether W; Schrinner E; Wagner WH
    Arzneimittelforschung; 1981; 31(8A):1317-22. PubMed ID: 7197538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide transport in Candida albicans: implications for the development of antifungal agents.
    Naider F; Becker JM
    Curr Top Med Mycol; 1988; 2():170-98. PubMed ID: 3288355
    [No Abstract]   [Full Text] [Related]  

  • 11. Direct cell penetration of the antifungal peptide, MMGP1, in Candida albicans.
    Pushpanathan M; Rajendhran J; Jayashree S; Sundarakrishnan B; Jayachandran S; Gunasekaran P
    J Pept Sci; 2012 Nov; 18(11):657-60. PubMed ID: 23080316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liberation of ciclopiroxolamine from dermatological preparations (author's transl)].
    Petri W
    Arzneimittelforschung; 1981; 31(8A):1332-7. PubMed ID: 7197540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans.
    Agut J; Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):718-20. PubMed ID: 1627190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activity of 4-hydroxy-3-(3-methyl-2-butenyl)acetophenone against Candida albicans: evidence for the antifungal mode of action.
    Soberón JR; Lizarraga EF; Sgariglia MA; Carrasco Juárez MB; Sampietro DA; Ben Altabef A; Catalán CA; Vattuone MA
    Antonie Van Leeuwenhoek; 2015 Nov; 108(5):1047-57. PubMed ID: 26342699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action mechanism of Hoe 296, a new synthetic antifungal preparation].
    Sakurai K; Sakaguchi T; Yamaguchi H; Iwata K
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):260. PubMed ID: 765565
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
    Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
    J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspofungin uptake is mediated by a high-affinity transporter in Candida albicans.
    Paderu P; Park S; Perlin DS
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3845-9. PubMed ID: 15388444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and antifungal activity of oligonucleotides in Candida albicans.
    Disney MD; Haidaris CG; Turner DH
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1530-4. PubMed ID: 12552085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2.
    Nishikawa H; Sakagami T; Yamada E; Fukuda Y; Hayakawa H; Nomura N; Mitsuyama J; Miyazaki T; Mukae H; Kohno S
    J Antimicrob Chemother; 2016 Jul; 71(7):1845-55. PubMed ID: 27090633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-fluorouracil altered morphology and inhibited growth of Candida albicans.
    Kesavan C; Joyee AG
    J Clin Microbiol; 2005 Dec; 43(12):6215-6. PubMed ID: 16333136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.